Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GC Rieber VivoMega is a leading Norwegian producer of high-quality omega-3 fish oil concentrates for the global nutraceutical and pharmaceutical markets. Based in Kristiansund, the company operates one of the world's most advanced production facilities, utilizing proprietary thin-film evaporation technology to achieve industry-leading purity and oxidation levels. Their product portfolio, marketed under the VivoMega brand, includes a wide range of EPA and DHA concentrations tailored for specific health benefits such as cardiovascular, brain, and eye health. The company is highly committed to sustainability, holding certifications from Friend of the Sea, MarinTrust, and IFOS. As a subsidiary of the GC Rieber Group, they leverage over a century of industrial expertise to provide reliable, science-based lipid solutions. Their manufacturing processes are GMP-certified, ensuring high standards for both dietary supplements and active pharmaceutical ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GC Rieber Oils.